News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
840,620 Results
Type
Article (86121)
Company Profile (702)
Press Release (753797)
Section
Business (232513)
Career Advice (4123)
Deals (39702)
Drug Delivery (127)
Drug Development (90877)
Employer Resources (195)
FDA (18049)
Job Trends (17304)
News (396095)
Policy (39676)
Tag
Academia (2983)
Alliances (56717)
Alzheimer's disease (1436)
Approvals (18003)
Artificial intelligence (273)
Bankruptcy (400)
Best Places to Work (12633)
Biotechnology (481)
Breast cancer (252)
Cancer (1927)
Cardiovascular disease (154)
Career advice (3524)
CAR-T (149)
Cell therapy (430)
Clinical research (72736)
Collaboration (756)
Compensation (396)
COVID-19 (2844)
C-suite (192)
Data (1753)
Diabetes (246)
Diagnostics (6850)
Earnings (95664)
Employer resources (166)
Events (128637)
Executive appointments (625)
FDA (19065)
Funding (678)
Gene therapy (302)
GLP-1 (788)
Government (5096)
Healthcare (20853)
Infectious disease (2977)
Interviews (811)
IPO (17774)
Job creations (5183)
Job search strategy (2860)
Layoffs (524)
Legal (10089)
Lung cancer (280)
Manufacturing (282)
Medical device (14538)
Medtech (14543)
Mergers & acquisitions (22315)
Metabolic disorders (661)
Neuroscience (1920)
NextGen: Class of 2025 (7679)
Non-profit (5077)
Northern California (2261)
Obesity (363)
Opinion (264)
Patents (187)
People (64865)
Pharmaceutical (143)
Phase I (22434)
Phase II (31588)
Phase III (23788)
Pipeline (833)
Postmarket research (3552)
Preclinical (10062)
Radiopharmaceuticals (265)
Rare diseases (373)
Real estate (7382)
Regulatory (26479)
Research institute (2651)
Resumes & cover letters (649)
Southern California (1947)
Startups (4284)
United States (20701)
Vaccines (734)
Weight loss (275)
Date
Today (176)
Last 7 days (923)
Last 30 days (3222)
Last 365 days (37465)
2025 (6160)
2024 (38138)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1269)
Arizona (248)
Asia (49817)
Australia (8782)
California (5269)
Canada (1790)
China (442)
Colorado (241)
Connecticut (263)
Europe (114160)
Florida (759)
Georgia (183)
Illinois (551)
Indiana (295)
Maryland (830)
Massachusetts (4118)
Michigan (225)
Minnesota (375)
New Jersey (1491)
New York (1490)
North Carolina (1013)
Northern California (2261)
Ohio (189)
Pennsylvania (1174)
South America (1649)
Southern California (1947)
Texas (779)
Utah (164)
Washington State (524)
There are 840,620 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
Pfizer Prepared to Reshore Manufacturing if Trump Makes Good on Tariff Threats
Last week, Eli Lilly also responded to the President’s tariff warnings by investing $27 billion to construct four manufacturing facilities across the U.S. in five years.
March 4, 2025
·
2 min read
·
Tristan Manalac
Antibody-drug conjugate (ADC)
AstraZeneca and Daiichi Sankyo’s Enhertu Enhances Stomach Cancer Case With Phase III Win
The partners are pushing to expand Enhertu’s list of indications beyond its standing uses in breast, lung and gastric cancers.
March 4, 2025
·
2 min read
·
Tristan Manalac
Neuropsychiatric disorders
Biohaven Disappoints Again, This Time in Phase II/III Bipolar Mania Trial
Biohaven in recent months has reported a clinical stumble in spinal muscular atrophy, alongside a Phase I readout for its protein degrader candidate that investors found underwhelming.
March 4, 2025
·
2 min read
·
Tristan Manalac
Podcast
A Conversation With Kevin Marks, CEO of Delphia
In the second podcast in a special series focused on
BioSpace
’s NextGen Class of 2025, Senior Editor Annalee Armstrong speaks with Kevin Marks, CEO of Delphia Therapeutics.
March 4, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Taiwan’s First Hospital to Achieve AMAM Stage 7 Certification!
March 4, 2025
·
3 min read
Press Releases
Tenaya Therapeutics Announces Pricing of Public Offering
March 4, 2025
·
5 min read
Press Releases
Celltrion receives U.S. FDA approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) biosimilars referencing PROLIA® and XGEVA®
March 4, 2025
·
12 min read
Press Releases
Full Year Trading Update
March 4, 2025
·
8 min read
Press Releases
Idorsia announces financial results for 2024
March 4, 2025
·
25 min read
Press Releases
ONWARD Medical to Advance Parkinson’s Disease Pipeline with Support from The Michael J. Fox Foundation and US Department of Defense
March 4, 2025
·
7 min read
1 of 84,062
Next
